Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
block further down, and Blade's raw-block scanner pairs an // inline β swallowing 140 lines of the article. $isDraftPreview = $isDraftPreview ?? false; @endphp
Orlistat blocks fat absorption rather than reducing appetite. Learn how Xenical and Alli work, XENDOS trial results, side effects and who they suit.
Orlistat works in a completely different way from every GLP-1 medication. It does not touch your appetite, your brain or your hormones. It sits in your gut and stops some of the fat you eat from being absorbed.
That difference explains both its modest results and its distinctive, well-earned reputation for unpleasant side effects.
Orlistat is sold as Xenical at 120 mg on prescription, and as Alli at 60 mg over the counter in many countries. Alli is the same drug at half the strength.
It has been available since 1999, which makes it one of the longest-established weight loss medications still in use. It was the standard option for years before GLP-1 drugs arrived.
Your body cannot absorb dietary fat directly. Fat molecules are too large, so an enzyme called lipase breaks them into smaller pieces your intestine can take up.
Orlistat blocks lipase. Specifically, it inhibits gastric and pancreatic lipase in your digestive tract.
The fat you eat that does not get broken down cannot be absorbed. It passes through and leaves your body in your stool.
At the 120 mg prescription dose, orlistat blocks roughly 30 percent of dietary fat absorption. At the 60 mg over-the-counter dose, closer to 25 percent.
Two features follow from this. First, orlistat is not absorbed into your bloodstream in any meaningful amount, so it has no systemic effects on your brain, heart or hormones. Second, it only works on fat. It does nothing about sugar, refined carbohydrates or total portion size.
The most substantial trial is XENDOS, published in Diabetes Care in 2004. It followed 3,305 people with obesity for four years, comparing orlistat 120 mg three times daily plus lifestyle changes against placebo plus lifestyle changes.
Average weight loss after four years was 5.8 kg on orlistat against 3.0 kg on placebo.
The more striking finding was about diabetes. Cumulative incidence of type 2 diabetes was 6.2 percent on orlistat against 9.0 percent on placebo, a relative risk reduction of 37.3 percent. That effect was concentrated in people who already had impaired glucose tolerance at the start.
Four years is an unusually long follow-up for a weight loss drug trial, and that longevity is genuinely valuable evidence.
But the weight number should be read plainly. A 2.8 kg difference over four years is a real effect and it is a modest one. For comparison, semaglutide averaged 14.9 percent body weight reduction in STEP 1 over 68 weeks, and tirzepatide averaged 20.9 percent in SURMOUNT-1 over 72 weeks.
Orlistat's side effects are almost entirely digestive, and they are direct consequences of undigested fat moving through your intestine.
The common ones include oily or fatty stools, urgent need to go, increased frequency, oily spotting, wind with discharge, and abdominal cramping.
These are not rare. They affect a large proportion of users, particularly early on.
Here is the part that makes orlistat unusual among medications. The side effects are proportional to how much fat you eat. A low-fat meal produces few or none. A large plate of fried food produces a great deal.
Some clinicians describe this as a built-in behavioural feedback loop. The drug effectively punishes high-fat eating, which teaches fat reduction through direct experience.
Whether that is a feature or simply an unpleasant side effect depends on your perspective. What is clear is that people who do not reduce dietary fat find orlistat close to intolerable.
Because orlistat blocks fat absorption, it also blocks absorption of the vitamins that dissolve in fat. That means vitamins A, D, E and K, plus beta-carotene.
A daily multivitamin is recommended, taken at least two hours away from an orlistat dose so it is not blocked as well. Most people take it at bedtime.
This matters more than it sounds. Vitamin D deficiency is already widespread across South Asia, and adding an absorption blocker on top of that is not trivial.
One capsule with each main meal containing fat, up to three times daily. Take it during the meal or within an hour after.
If a meal contains no fat, you skip that dose. There is nothing for the drug to act on.
Fat intake should be spread across meals rather than concentrated in one, and around 30 percent of daily calories from fat is the usual guidance. Loading all your fat into one meal produces a miserable afternoon.
It genuinely suits some people.
Someone whose eating pattern is high in fried and fatty food has the most to gain, because that is exactly what orlistat acts on. Someone who cannot take GLP-1 medication for medical reasons, or who cannot tolerate the nausea, has a real alternative here. And someone who wants something that stays in the gut without systemic effects may prefer it on that basis.
It suits nobody whose problem is portion size, sugar or refined carbohydrates. Orlistat does nothing about any of those.
Orlistat is one of the more accessible weight loss medications here. It does not require refrigeration, it is not import-dependent in the way GLP-1 injections are, and generic versions are widely available.
That accessibility is a genuine advantage over drugs you cannot reliably obtain.
The limitation is what it does. Typical Pakistani eating patterns are frequently high in refined carbohydrates, roti, rice and sugar as much as in fat. Orlistat has no effect on any of those. Someone whose calories come mainly from rice and sweet chai will see very little from it.
Appetite is the other half of the equation, and orlistat does not touch it. That is where GLP-1 pathway support does its work, by reducing how much you want to eat in the first place rather than blocking a fraction of what you have already eaten. If you are weighing one option worth understanding against orlistat, the two work on genuinely different problems. METASLIMβ’ is a physician-reviewed GLP-1 sublingual supplement addressing appetite, with a physician reviewing each order. Orlistat addresses fat absorption. Which fits depends entirely on why you are overeating.
Our guide to Ozempic alternatives maps the full field, and what Saxenda is covers the injectable side. You can also compare medical weight loss options in one place.
Orlistat works, modestly. XENDOS showed 5.8 kg over four years against 3.0 kg on placebo, plus a meaningful reduction in progression to type 2 diabetes.
Its side effects are entirely digestive and scale directly with dietary fat. It blocks fat-soluble vitamins, so supplementation is required.
It is accessible, affordable and needs no cold chain, which counts for a lot in Pakistan. It does nothing for appetite, portion size or carbohydrate intake, which counts against it for most people here.
Find out what the program costs if appetite rather than fat absorption is your actual problem.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.
METASLIMβ’ is a physician-guided GLP-1 sublingual program β injection-free appetite support, designed for sustainable weight loss.
Orlistat blocks lipase, the enzyme that breaks dietary fat into pieces small enough for your intestine to absorb. Around 30 percent of the fat you eat passes through undigested at the 120 mg prescription dose. It has no effect on appetite, sugar or carbohydrates.
The four-year XENDOS trial recorded 5.8 kg average weight loss on orlistat against 3.0 kg on placebo, a difference of 2.8 kg. This is a real but modest effect, well below what GLP-1 medications like semaglutide and tirzepatide achieve over shorter periods.
Both contain orlistat. Xenical is the 120 mg prescription strength, blocking roughly 30 percent of dietary fat. Alli is the 60 mg over-the-counter version, blocking closer to 25 percent. The drug and mechanism are identical, only the dose differs.
The fat orlistat prevents you absorbing has to leave your body, and it does so in your stool. Effects include oily stools, urgency, increased frequency and oily spotting. Their severity depends directly on how much fat you eat at each meal.
Yes. Because orlistat blocks fat absorption, it also blocks the fat-soluble vitamins A, D, E and K along with beta-carotene. A daily multivitamin is recommended, taken at least two hours apart from an orlistat dose, most commonly at bedtime.
No, on weight loss results. Orlistat produced 5.8 kg over four years in XENDOS, while semaglutide averaged 14.9 percent body weight reduction over 68 weeks in STEP 1. Orlistat's advantages are accessibility, affordability and no refrigeration requirement rather than effectiveness.
Very little. Orlistat only blocks fat absorption and has no effect on carbohydrates, sugar or portion size. Someone whose calories come mainly from rice, roti and sweet drinks will see minimal benefit, because there is comparatively little dietary fat for the drug to act on.